search
Back to results

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

Primary Purpose

Sickle Cell Anemia, Sickle Cell Thalassemia, Iron Overload

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Cardiac and Liver T2* MRI
Sponsored by
HaEmek Medical Center, Israel
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Sickle Cell Anemia focused on measuring Sickle Cell Anemia, Sickle Cell Thalassemia, Iron Overload, MRI

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All the patients with Sickle cell anemia and Sickle cell Thalasemia that are currently in follow up at the Pediatric Hematology Unit

Exclusion Criteria:

  • Age below 18 years.

Sites / Locations

  • Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center

Outcomes

Primary Outcome Measures

Assessment of Iron overload.

Secondary Outcome Measures

Institute the criteria for iron chelator treatment

Full Information

First Posted
August 5, 2007
Last Updated
August 25, 2011
Sponsor
HaEmek Medical Center, Israel
Collaborators
Wolfson Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00512226
Brief Title
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
Official Title
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2011
Overall Recruitment Status
Completed
Study Start Date
September 2007 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
HaEmek Medical Center, Israel
Collaborators
Wolfson Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't develope significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpouse of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and cardiac T2*MRI in order to determine the cardiac and liver iron.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sickle Cell Anemia, Sickle Cell Thalassemia, Iron Overload, MRI
Keywords
Sickle Cell Anemia, Sickle Cell Thalassemia, Iron Overload, MRI

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
Cardiac and Liver T2* MRI
Intervention Description
Laboratory examinations that are routinely used in follow up of those patients and T2* MRI analysis.
Primary Outcome Measure Information:
Title
Assessment of Iron overload.
Time Frame
December 2008
Secondary Outcome Measure Information:
Title
Institute the criteria for iron chelator treatment
Time Frame
December 2008

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All the patients with Sickle cell anemia and Sickle cell Thalasemia that are currently in follow up at the Pediatric Hematology Unit Exclusion Criteria: Age below 18 years.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ariel Koren, MD
Organizational Affiliation
Pediatric Hematology Unit, Ha'Emek Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
City
Afula
ZIP/Postal Code
18101
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

We'll reach out to this number within 24 hrs